Presentation TCT 2023 The Spectrum of Devices for Acute Decompensated Heart Failure: Which Patients Will Benefit? Presenter: Daniel Burkhoff October 26, 2023
Presentation TCT 2023 Acute Decompensated HF Trials: Who Should be Enrolled and What Should the Study Endpoints Be? Presenter: JoAnn Lindenfeld October 25, 2023
News Conference News ESC 2023 Early SGLT2 Inhibition, Spot Urine Sodium Checks May Help in Acute HF Todd Neale September 01, 2023
News Conference News ESC 2023 IV Iron in HF Misses (Again) in HEART-FID, but Meta-analysis Sees a Role Shelley Wood August 26, 2023
News Daily News SGLT2i May Be Helpful Early After Acute MI in Diabetic Patients Todd Neale July 17, 2023
News Daily News Frail Patients Also Benefit From Intensive BP Lowering: SPRINT Analysis Todd Neale July 10, 2023
News Daily News Congestion Biomarker CA125 Signals Worse Outcomes in Ambulatory HFrEF Todd Neale July 03, 2023
News Daily News PA Catheters in Cardiogenic Shock: Patchy Usage, Potential Gains Shelley Wood June 22, 2023
Presentation TVT 2023 Devices for Acute Decompensated Heart Failure Presenter: Daniel Burkhoff June 08, 2023
News Conference News ESC Heart Failure 2023 More ARNI Insights Fortify Role in ‘Below Normal’ LVEF: PARAGLIDE-HF Shelley Wood May 22, 2023
Presentation THT 2023 Pilot Evaluation of the Use of Prolonged Low-Intensity Ultrasound Delivery to the Kidney in Acutely Decompensated Heart Failure Patients With Renal Deficiency Presenter: Benny Rousso March 21, 2023
Presentation THT 2023 Prolonged Low-intensity Ultrasound Delivery to the Kidney, As a Technology For Potential Treatment Option For Acutely Decompensated Heart Failure Patients With Renal Deficiency Presenter: Benny Rousso March 21, 2023
Presentation THT 2023 What Are Clinically Meaningful and Practical Pivotal Trial Endpoints for Effectiveness and Safety to Demonstrate an Acceptable Benefit-Risk Profile? Presenter: Maria Rosa Costanzo March 20, 2023
Presentation THT 2023 Invasive Investigational Device IDE Studies: For Diuretic-Resistant Patients Only? Presenter: Ulrich Jorde March 20, 2023
News Daily News Cardiogenic Shock Outcomes Markedly Worse in De Novo HF Patients Caitlin E. Cox December 09, 2022
News Daily News Analysis Cements Benefits of SGLT2 Inhibitors in HF, but Diabetes Matters for Deaths Michael O'Riordan December 08, 2022
News Conference News AHA 2022 New Tool Assesses Risk in Acute HF Then Suggests Next Steps, Cutting Later Events Yael L. Maxwell November 07, 2022
News Daily News SPRINT Turns Sluggish: Mortality Benefits Vanish Once Normal BP Care Resumes Michael O'Riordan October 18, 2022